SA
RPRX logo
Royalty Pharma plc(RPRX)
Closing price · checked 8:37 PM ETAbout this dataData status
$68.45▲0.73 (1.08%)
Extended:$67.65-0.80 (-1.17%)· 8:37 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Royalty Pharma plc (RPRX)

Stock-Based Compensation

$354.83M

TTM · Period ending: · USD

RPRX logo

RPRX Stock-Based Compensation

Latest reported$354.83M
RPRX Stock-Based Comp ($0.00 → $354.83M)
High-resolution chart · PNG

What is stock-based compensation?

Non-cash compensation expense paid in equity.

RPRX stock-based compensation history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Royalty Pharma plc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)Change
289,894,000+12,267.49%
2,344,000−0.55%
2,357,000+8.62%
2,170,000−11.17%
2,443,000−54.99%
5,428,000—
0—
0—
0—

Frequently asked questions: RPRX stock-based compensation

What is Royalty Pharma plc (RPRX)'s current stock-based compensation?

Royalty Pharma plc (RPRX)'s latest reported stock-based compensation (TTM) is $354.83M as of Sep 30, 2026. Non-cash compensation expense paid in equity.

How much historical stock-based compensation data is available for RPRX?

Stock Alarm Pro provides 9 dated annual fiscal periods observations for Royalty Pharma plc (RPRX)'s stock-based compensation, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare RPRX's stock-based compensation to peers or set an alert?

You can open RPRX's stock-based compensation in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on RPRX delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.